Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Tipo de estudio
Intervalo de año
1.
Saudi Medical Journal. 2009; 30 (9): 1228-1230
en Inglés | IMEMR | ID: emr-102317

RESUMEN

UndifFerentiated spondyloarthropathies [USPA] can sometimes be refractory to usual disease modifying agents. Anti-tumor necrosis factor [TNF] -alpha agents have been shown to be effective in spondyloarthropathies. Few articles described the efficacy of TNF-alpha antagonists in USPA. Our patient had refractory Achilles tendonitis as an early manifestation of USPA which responded dramatically to infliximab treatment


Asunto(s)
Humanos , Masculino , Animales , Anticuerpos Monoclonales , Tendinopatía/tratamiento farmacológico , Imagen por Resonancia Magnética , Anticuerpos Monoclonales/farmacología , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Antiinflamatorios
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA